Stablecoin Development (SDEV) vs Talphera (TLPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Talphera (TLPH) has outperformed Stablecoin Development (SDEV) over the past year, losing 41.4% versus a loss of 88.4%. Over five years, TLPH leads with a -94.0% price change compared with -100.0% for SDEV. Talphera is the larger company by market cap ($40.8 million vs $36.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SDEV | TLPH |
|---|---|---|
| Share price | $0.50 | $0.7852 |
| Market cap | $36.90M | $40.80M |
| 1-day change | -10.30% | +6.25% |
| YTD return | -98.23% | -31.12% |
| 1-year return | -88.37% | -41.40% |
| 5-year return | -99.98% | -93.96% |
| P/E ratio (TTM) | 0.19 | — |
| EPS (TTM) | $2.70 | $-0.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $28.00K |
| Net income (latest FY) | $-630.78M | $-14.29M |
| Operating margin | — | -48157.14% |
| Net margin | — | -51035.71% |
| 52-week high | $99.75 | $1.57 |
| 52-week low | $0.467 | $0.69 |
| Distance from 52-week high | -99.50% | -49.99% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +298.62% |
| Average volume | 16.98M | 144.13K |
| Shares outstanding | 73.80M | 51.96M |
| Employees | 2 | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TLPH has outperformed SDEV by 47.0 percentage points over the past year.
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
About Talphera
TLPH stock →Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
SDEV vs TLPH FAQ
Which is bigger, Stablecoin Development or Talphera?
Talphera (TLPH) is larger, with a market capitalization of $40.80M compared with $36.90M for Stablecoin Development (SDEV).
Which stock has performed better over the past year, SDEV or TLPH?
TLPH returned -41.40% over the past 12 months, compared with -88.37% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are Stablecoin Development and Talphera in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.